<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04511910</url>
  </required_header>
  <id_info>
    <org_study_id>CholeRisk Score</org_study_id>
    <nct_id>NCT04511910</nct_id>
  </id_info>
  <brief_title>How to Predict Postoperative Complications After Early Laparoscopic Cholecystectomy for Acute Cholecystitis: the Chole-Risk Score</brief_title>
  <acronym>CholeRiskScore</acronym>
  <official_title>How to Predict Postoperative Complications After Early Laparoscopic Cholecystectomy for Acute Cholecystitis: the Chole-Risk Score</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundación de Investigación Biomédica - Hospital Universitario de La Princesa</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Marcello Di Martino</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fundación de Investigación Biomédica - Hospital Universitario de La Princesa</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Acute calculous cholecystitis (ACC) is the most common complication of gallstone disease, and&#xD;
      laparoscopic cholecystectomy is the gold standard treatment. Several prospective studies have&#xD;
      demonstrated that same-admission, early LC (ELC), for ACC is safe when compared with delayed&#xD;
      LC (DLC). However, there is still controversy on the indication of ELC in high risk patients&#xD;
      with important comorbidities, in cases of severe inflammation of the gallbladder and in&#xD;
      patients with ACC and suspicious of a choledocholithiasis. The advantages of ELC in high risk&#xD;
      patients with severe comorbidities have been recently questioned, with Tokyo Guidelines 2018&#xD;
      (TG18) proposing an initial conservative management of this cases, assessing the benefit of&#xD;
      ELC according to specified criteria. However, the recent CHOCOLATE trial, demonstrated the&#xD;
      advantages of ELC over an initial conservative management. Performing an ELC for ACC can be a&#xD;
      straightforward procedure for an on-call general surgeon or a very challenging procedure even&#xD;
      for experienced hepatopancreaticobiliary (HPB) laparoscopic surgeon, depending on disease&#xD;
      features, surgeons experience, centres volumes and resources available. Deciding whether the&#xD;
      ELC should be performed by the on-call team or by HPB surgical team, or whether the operation&#xD;
      should be delayed are still matter of debate in daily practice.&#xD;
&#xD;
      Several preoperative scores assessing the risk of difficult cholecystectomy have been&#xD;
      proposed, but they were mainly focused on elective procedures and on risk of conversion to&#xD;
      open cholecystectomy or other intraoperative complications. They did not asses the risk of&#xD;
      post-operative complications in a subgroup of patients, for whom, indication to ELC by the&#xD;
      on-call general surgeon is still questionable according to the more recent guidelines.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2013</start_date>
  <completion_date type="Actual">September 30, 2020</completion_date>
  <primary_completion_date type="Actual">July 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Increased post-operative complications</measure>
    <time_frame>For at least 30 postoperative days</time_frame>
    <description>Patients who only developed Clavien-Dindo I-II complications were assigned to group 1 (G1), whereas groups 2 (G2) included patients with post-operative complications ≥ IIIa. Patients with post-operative LOS greater than 10 days and who required readmissions within 30 days from the discharge were also assigned to G2.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants with Postoperative hemorrhagia</measure>
    <time_frame>For at least 30 postoperative days</time_frame>
    <description>Postoperative hemorrhagia</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants with Biliary fistula</measure>
    <time_frame>For at least 30 postoperative days</time_frame>
    <description>Biliary fistula</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants with Jaundice</measure>
    <time_frame>For at least 30 postoperative days</time_frame>
    <description>Jaundice</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants with Cardiac insufficiency</measure>
    <time_frame>For at least 30 postoperative days</time_frame>
    <description>Cardiac insufficiency</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants with Heart infarction</measure>
    <time_frame>For at least 30 postoperative days</time_frame>
    <description>Heart infarction</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants with Respiratory insufficiency</measure>
    <time_frame>For at least 30 postoperative days</time_frame>
    <description>Respiratory insufficiency</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants with Pulmonary thromboembolism</measure>
    <time_frame>For at least 30 postoperative days</time_frame>
    <description>Pulmonary thromboembolism</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants with Kidney failure or dialysis</measure>
    <time_frame>For at least 30 postoperative days</time_frame>
    <description>Kidney failure or dialysis</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">1868</enrollment>
  <condition>Cholecystitis, Acute</condition>
  <arm_group>
    <arm_group_label>Early surgery Group 1</arm_group_label>
    <description>The surgery is performed within the first 3 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Early surgery Group 2</arm_group_label>
    <description>Surgery is performed between the fourth and seventh day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Early surgery Group 3</arm_group_label>
    <description>Surgery is performed more than 7 days from the onset of symptoms</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Early Laparoscopic Cholecystectomy</intervention_name>
    <arm_group_label>Early surgery Group 1</arm_group_label>
    <arm_group_label>Early surgery Group 2</arm_group_label>
    <arm_group_label>Early surgery Group 3</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        CLP surgery patients between January 2013 and December 2018. The diagnosis of acute&#xD;
        cholecystitis will be established according to the Tokio Guidelines:&#xD;
&#xD;
          -  Local signs (pain in right hypochondrium / Murphy's sign).&#xD;
&#xD;
          -  Systemic (fever / elevated C-reactive protein / leukocytosis)&#xD;
&#xD;
          -  Ultrasound findings (gallbladder distension, wall thickening, pericolectic fluid or&#xD;
             radiological Murphy's sign, associated with gallstones). In all patients, treatment&#xD;
             with antibiotics will be carried out according to each hospital's protocols in terms&#xD;
             of type and duration.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients aged 18 years or older diagnosed with Acute calculous cholecystitis.&#xD;
&#xD;
          -  Consecutive patients undergoing early laparoscopic cholecystectomy between January&#xD;
             2013 and December 2018 during admission for the acute episode.&#xD;
&#xD;
          -  Minimum 30-day post-operative follow-up.&#xD;
&#xD;
          -  ASA ≤ 3.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Presence of another concomitant pathology of the bile duct (choledocholithiasis,&#xD;
             cholangitis, pancreatitis, biliary peritonitis).&#xD;
&#xD;
          -  Aetiology other than cholelithiasis (amythiasis, malignancy).&#xD;
&#xD;
          -  Patients with severe sepsis, immunosuppression and pregnancy.&#xD;
&#xD;
          -  Additional abdominal surgical procedure.&#xD;
&#xD;
          -  ASA 4.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospital de Cabueñes</name>
      <address>
        <city>Gijón</city>
        <state>Asturias</state>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario German Trias I Pujol</name>
      <address>
        <city>Badalona</city>
        <state>Barcelona</state>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Marqués de Valdecilla</name>
      <address>
        <city>Santander</city>
        <state>Cantabria</state>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Príncipe de Asturias</name>
      <address>
        <city>Alcalá De Henares</city>
        <state>Madrid</state>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Cruces</name>
      <address>
        <city>Bilbao</city>
        <state>Vizcaya</state>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de la Princesa</name>
      <address>
        <city>Madrid</city>
        <zip>28006</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital General Universitario Gregorio Marañón</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario La Paz</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Ramón y Cajal</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Complejo Asistencial Universitario Salamanca</name>
      <address>
        <city>Salamanca</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen del Rocío</name>
      <address>
        <city>Sevilla</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>August 11, 2020</study_first_submitted>
  <study_first_submitted_qc>August 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 13, 2020</study_first_posted>
  <last_update_submitted>March 26, 2021</last_update_submitted>
  <last_update_submitted_qc>March 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Acute cholecystitis</keyword>
  <keyword>Cholecystectomy</keyword>
  <keyword>Gallbladder</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cholecystitis</mesh_term>
    <mesh_term>Acalculous Cholecystitis</mesh_term>
    <mesh_term>Cholecystitis, Acute</mesh_term>
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

